Skip to main content

Table 3 Association between HSV/CMV reactivation and clinical outcomes

From: Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO

 

Coefficient

p value

Mechanical ventilation duration

 Viral reactivation

4.01

< 0.01

ECMO duration

 Viral reactivation

1.64

0.32

ICU length of stay

 Viral reactivation

− 3.63

0.03

Hospital length of stay

 Viral reactivation

0.82

0.73

  1. Multivariate analysis evaluating, after adjustment on patients’ severity and length of MV and ECMO duration before reactivation, the clinical impact of HSV/CMV reactivation. The coefficient designates the number of days by which the different endpoints are affected